JPRN-UMIN000024995Completed未知
A study for evaluating the immune response by ingestion of a fucoidan-containing food in adult males and females : a randomized, double blind, placebo-controlled, parallel-group trial - A study for evaluating the immune response by ingestion of a fucoidan-containing food in adult males and females
TTC Co., Ltd.0 sites60 target enrollmentStarted: November 27, 2016Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 65years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Subjects who use fucoidan-containing food or fucoidan fortified food 2) Subjects taking medicine and quasi drug (e.g., immunosuppressant, steroid) which may influence immune function 3) Subjects routinely taking health supplements which may influence immune function 4) Subjects who are under medication (e.g., hyposensitization) which may influence the outcome of the study 5) Subjects who have a history of the allergic disease 6) Subjects who have treated oral or dental care within the last one month prior to the current study or are planned to treat oral or dental care 7) Subjects who have oral or dental problems with bleeding 8) Night and day shift worker or manual laborer 9) Subjects who have carried out an intense activity (e.g., marathon race) 10) Subjects who cannot carry out a procedure of various inspection by the rule during the study period 11) Subjects who have a disease under treatment or are judged to that medical treatment are necessary by the doctor 12) Subjects who have under treatment or a history of serious disease (e.g., diabetes, liver disease, kidney disease, or heart disease) and disease to affect the adrenal cortical hormone secretion 13) Subjects having possibilities for emerging allergy related to the study 14) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination 15) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating 16) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study 17) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire 18) Subjects who are judged as unsuitable for the study by the investigator for other reason
Investigators
Similar Trials
Completed
Phase 1
A study to evaluate the immunogenicity and safety of smallpox vaccine as vaccination to monkeypox in healthy adultsMonkeypoxJPRN-jRCTs031220171jiie Mugen50
Completed
Unknown
A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK)ot applicableJPRN-UMIN000051748Suntory Wellness Limited200
Completed
Phase 2
The Study of Dose Response Relationship Evaluation of AryoSeven in Hemophilia PatientsCondition 1: Congenital Hemophilia A with inhibitors. Condition 2: Congenital Hemophilia B with inhibitors.Hereditary factor VIII deficiencyHereditary factor IX deficiencyIRCT20161202031193N3AryoGen Pharmed12
Completed
Not Applicable
A study to evaluate the dose-response effect of tolvaptan 7.5mg or 15mg in HF patients who undergo cartdiac angiographyHeart FailureJPRN-UMIN000009924Showa University Northern Hospital100
Completed
Unknown
A study to evaluate how the intake of the test beverage and the watching of a video while taking it impacts psychology and cognitive functioning.Healthy subjectsJPRN-UMIN000052562HUMA R&D CORP120